The MEDomics mitochondrial genome test, MitoDx(TM), uses the revolutionary NextGen sequencing technology...TorreyPines Therapeutics Announces its Board of Directors' Approval of Plan of Liquidation and Dissolution... company's goal has been to develop versatile product candidates each capable of treating a number of acute and chronic diseases and disorders such as migraine and chronic pain.